Park Place Capital Corp Spring Works Therapeutics, Inc. Transaction History
Park Place Capital Corp
- $319 Million
- Q3 2024
A detailed history of Park Place Capital Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 28 shares of SWTX stock, worth $1,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 28
-0.0%
Holding current value
$1,204
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$289 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$242 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$165 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$151 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$147 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.68B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...